HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yu-Sun Chang Selected Research

hydrocotarnine

10/2018Src-family kinase-Cbl axis negatively regulates NLRP3 inflammasome activation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yu-Sun Chang Research Topics

Disease

78Neoplasms (Cancer)
01/2022 - 08/2005
42Nasopharyngeal Carcinoma
06/2021 - 01/2002
18Neoplasm Metastasis (Metastasis)
11/2018 - 11/2007
11Squamous Cell Carcinoma of Head and Neck
10/2020 - 08/2008
10Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 01/2008
10Mouth Neoplasms (Oral Cancer)
01/2022 - 07/2009
10Urinary Bladder Neoplasms (Bladder Cancer)
07/2018 - 11/2010
8Carcinogenesis
05/2015 - 12/2004
7Lung Neoplasms (Lung Cancer)
04/2015 - 10/2009
6Inflammation (Inflammations)
02/2019 - 12/2012
5Infections
01/2019 - 03/2011
5Adenocarcinoma of Lung
05/2017 - 10/2009
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2016 - 10/2009
5Carcinoma (Carcinomatosis)
09/2015 - 07/2002
4Hernia (Hernias)
07/2018 - 06/2012
4Breast Neoplasms (Breast Cancer)
05/2016 - 04/2007
4Adenocarcinoma
01/2016 - 05/2011
4Pleural Effusion (Pleural Effusions)
04/2015 - 10/2009
3Myocardial Infarction
12/2020 - 01/2014
3Melanoma (Melanoma, Malignant)
01/2020 - 11/2012
3Hematuria
07/2018 - 06/2012
3Urinary Tract Infections (Urinary Tract Infection)
07/2018 - 06/2012
3Stomach Neoplasms (Stomach Cancer)
04/2015 - 05/2010
3Lymphoma (Lymphomas)
12/2011 - 06/2002
2Lymphatic Metastasis
01/2020 - 11/2013
2Colitis
02/2019 - 10/2018
2Acute Kidney Injury (Acute Renal Failure)
01/2019 - 01/2016
2Fibrosis (Cirrhosis)
01/2019 - 01/2016
2Glioma (Gliomas)
05/2017 - 09/2011
2Ovarian Neoplasms (Ovarian Cancer)
05/2017 - 10/2014
2Kidney Neoplasms (Kidney Cancer)
05/2017 - 06/2013
2Malignant Pleural Effusion
06/2014 - 10/2011
2Pancreatic Neoplasms (Pancreatic Cancer)
03/2013 - 01/2011
2Esophageal Squamous Cell Carcinoma
03/2012 - 02/2011
1Obesity
01/2022
1Weight Loss (Weight Reduction)
01/2022
1Cardiovascular Diseases (Cardiovascular Disease)
12/2020
1Hemolysis
12/2020

Drug/Important Bio-Agent (IBA)

47Proteins (Proteins, Gene)FDA Link
11/2020 - 12/2004
40Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2008
12MicroRNAs (MicroRNA)IBA
01/2022 - 11/2008
10Pharmaceutical PreparationsIBA
01/2022 - 09/2011
10Messenger RNA (mRNA)IBA
08/2016 - 12/2008
10Membrane Proteins (Integral Membrane Proteins)IBA
08/2016 - 07/2002
10ProteomeIBA
09/2015 - 08/2005
9InflammasomesIBA
01/2020 - 11/2012
9DNA (Deoxyribonucleic Acid)IBA
01/2020 - 08/2008
8RNA (Ribonucleic Acid)IBA
01/2022 - 11/2013
7Tumor Biomarkers (Tumor Markers)IBA
08/2016 - 08/2005
6Biological ProductsIBA
01/2020 - 08/2009
5Carrier Proteins (Binding Protein)IBA
11/2012 - 12/2008
4CytokinesIBA
01/2014 - 02/2011
3HLA Antigens (Human Leukocyte Antigens)IBA
01/2021 - 01/2012
3Leukemia Inhibitory FactorIBA
11/2018 - 12/2013
3Phosphotransferases (Kinase)IBA
11/2018 - 06/2002
3ImmunosorbentsIBA
07/2018 - 05/2010
3EnzymesIBA
07/2018 - 05/2010
3Peptides (Polypeptides)IBA
10/2017 - 06/2012
3InterferonsIBA
08/2016 - 07/2009
3Karyopherins (Importin)IBA
05/2016 - 05/2011
3Heterogeneous-Nuclear Ribonucleoprotein KIBA
05/2014 - 06/2008
3CalciumIBA
12/2012 - 02/2011
3Thymidine PhosphorylaseIBA
06/2012 - 06/2008
3AutoantibodiesIBA
05/2011 - 05/2010
2Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA
01/2022 - 03/2020
2Epidermal Growth Factor (EGF)IBA
06/2021 - 05/2016
2palbociclibIBA
06/2021 - 09/2018
2Histidine (L-Histidine)FDA Link
11/2020 - 01/2018
2Glutamine (L-Glutamine)FDA Link
11/2020 - 01/2018
2chlorotriphenylsilane (CTPS)IBA
11/2020 - 01/2018
2Dextrans (Dextran)FDA Link
02/2019 - 10/2018
2SodiumIBA
10/2018 - 03/2012
2Uric Acid (Urate)IBA
01/2017 - 10/2016
2ErbB Receptors (EGF Receptor)IBA
05/2016 - 04/2007
2Conditioned Culture MediaIBA
09/2015 - 01/2008
2MetalsIBA
09/2015 - 03/2013
2IsotopesIBA
04/2015 - 11/2012
2Amino AcidsFDA Link
04/2015 - 11/2012
2Cadherins (E-Cadherin)IBA
02/2014 - 07/2002
2Oncogene Proteins (Oncogene Protein)IBA
02/2014 - 07/2010
2Indicators and Reagents (Reagents)IBA
01/2013 - 02/2011
2AntibodiesIBA
01/2013 - 08/2008
2Apolipoprotein A-I (Apolipoprotein A1)IBA
01/2013 - 11/2010
2Apolipoprotein A-II (Apolipoprotein A2)IBA
06/2012 - 11/2010
2doxifluridineIBA
06/2012 - 06/2008
2RibonucleoproteinsIBA
06/2012 - 06/2008
2Carcinoembryonic AntigenIBA
05/2011 - 05/2010
2Differentiation AntigensIBA
03/2011 - 06/2010
2AntigensIBA
12/2008 - 08/2008
1AfatinibIBA
06/2021
1Cetuximab (Erbitux)FDA Link
06/2021
1Growth Factor ReceptorsIBA
06/2021
1Hemoglobins (Hemoglobin)IBA
12/2020
1Circular RNAIBA
10/2020

Therapy/Procedure

7Therapeutics
01/2022 - 09/2011
2Lasers (Laser)
09/2015 - 10/2014
2Radiotherapy
01/2014 - 11/2007
2Chemoradiotherapy
03/2012 - 02/2011
1Precision Medicine
01/2022
1Bariatric Surgery
01/2022